A-kinase anchoring proteins as potential drug targets

British Journal of Pharmacology

Volumn 166, Issue 2, 2012, Pages 420-433

  Tröger, Jessica ^a   Moutty, Marie C ^a,b   Skroblin, Philipp ^a   Klussmann, Enno ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

AKAP; aquaporin; drug targets; heart failure; PKA; small molecules

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 10; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 13; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 4; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 5; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 6; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 9; NEUROBEACHIN; PERICENTRIN; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG; WAVE 1 PROTEIN;

ALZHEIMER DISEASE; AUTISM; BREAST CANCER; CELL COMPARTMENTALIZATION; CELL COMPOSITION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG RESEARCH; DRUG TARGETING; DWARFISM; FEMALE INFERTILITY; GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LEARNING DISORDER; LONG QT SYNDROME; MAJOR DEPRESSION; MALE INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MEMORY DISORDER; MOTOR DYSFUNCTION; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERINATAL DEATH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

A KINASE ANCHOR PROTEINS; ANIMALS; DRUG DESIGN; HUMANS; SIGNAL TRANSDUCTION;

EID: 84859902380     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01796.x     Document Type: Review

References (155)

1. Aandahl EM, Aukrust P, Skalhegg BS, Muller F, Froland SS, Hansson V, et al,. (1998). Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J 12: 855-862. (Pubitemid 28294675)
2. Aandahl EM, Aukrust P, Muller F, Hansson V, Tasken K, Froland SS, (1999). Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. Aids 13: F109-F114.
3. Akakura S, Huang C, Nelson PJ, Foster B, Gelman IH, (2008). Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Cancer Res 68: 5096-5103.
4. Alto NM, Soderling SH, Hoshi N, Langeberg LK, Fayos R, Jennings PA, et al,. (2003). Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring. Proc Natl Acad Sci U S A 100: 4445-4450. (Pubitemid 36457750)
5. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D, (2007). The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates 1 adrenergic receptor-induced cardiomyocyte hypertrophy. PNAS 104: 10140-10145. (Pubitemid 47175276)
6. Aye TT, Soni S, van Veen TA, van der Heyden MA, Cappadona S, Varro A, et al,. (2011). Reorganized PKA-AKAP associations in the failing human heart. J Mol Cell Cardiol. Epub ahead of print.
7. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, et al,. (2008). Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol 52: 1640-1648.
8. Burns-Hamuro LL, Ma Y, Kammerer S, Reineke U, Self C, Cook C, et al,. (2003). Designing isoform-specific peptide disruptors of protein kinase A localization. Proc Natl Acad Sci USA 100: 4072-4077. (Pubitemid 36418159)
9. Carlson CR, Lygren B, Berge T, Hoshi N, Wong W, Tasken K, et al,. (2006). Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem 281: 21535-21545. (Pubitemid 44115490)
10. Carnegie G, Soughayer J, Smith F, Pedroja B, Zhang F, Diviani D, et al,. (2008). AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 32: 169-179.
11. Carnegie GK, Burmeister BT, (2011). AKAPs that regulate cardiac remodeling. J Cardiovasc Pharmacol 1: 451-458.
12. Carnegie GK, Means CK, Scott JD, (2009). A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 61: 394-406.
13. Carrera A, Gerton GL, Moss SB, (1994). The major fibrous sheath polypeptide of mouse sperm: structural and functional similarities to the A-kinase anchoring proteins. Dev Biol 165: 272-284. (Pubitemid 24306120)
14. Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L, et al,. (2003). The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet 40: 352-356. (Pubitemid 36613473)
15. Chen HH, Schrier RW, (2006). Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119 (Suppl. 1): S11-S16. (Pubitemid 44738815)
16. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS, (2007). Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A 104: 20990-20995.
17. Chiriva-Internati M, Ferrari R, Yu Y, Hamrick C, Gagliano N, Grizzi F, et al,. (2008). AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol 140: 465-468.
18. Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, Cannon MJ, et al,. (2011). Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Prostate 72: 12-23.
19. Christian F, Szaszak M, Friedl S, Drewianka S, Lorenz D, Goncalves A, et al,. (2011). Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem 286: 9079-9096.
20. Colas P, (2008). High-throughput screening assays to discover small-molecule inhibitors of protein interactions. Curr Drug Discov Technol 5: 190-199.
21. Cornez I, Tasken K, (2010). Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells. FEBS Lett 584: 2681-2688.
22. Daino K, Roch-Lefevre S, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S, (2009). Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas. Biochem Biophys Res Commun 390: 654-658.
23. Delint-Martinez I, Willoughby D, Hammond GV, Ayling LJ, Cooper DM, (2011). Palmitoylation targets AKAP79 to lipid rafts and promotes its regulation of the calcium sensitive adenylyl cyclase type 8. J Biol Chem 286: 32962-32975.
24. Dell'Acqua ML, Faux MC, Thorburn J, Thorburn A, Scott JD, (1998). Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4, 5-bisphosphate. EMBO J 17: 2246-2260. (Pubitemid 28171910)
25. Diviani D, Langeberg LK, Doxsey SJ, Scott JD, (2000). Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain. Curr Biol 10: 417-420. (Pubitemid 30213391)
26. Diviani D, Sonderling J, Scott JD, (2001). AKAP-Lbc anchors protein kinase A and nucleates galpha 12-selective rho-mediated stress fiber formation. J Biol Chem 276: 44247-44257.
27. Diviani D, Dodge-Kafka KL, Li J, Kapiloff MS, (2011). A-kinase anchoring proteins-scaffolding proteins in the heart. Am J Physiol Heart Circ Physiol 301: H1742-H1753.
28. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, et al,. (2005). The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437: 574-578. (Pubitemid 41613557)
29. Dodge-Kafka KL, Bauman A, Kapiloff MS, (2008). A-kinase anchoring proteins as the basis for cAMP signaling. Handb Exp Pharmacol 186: 3-14.
30. Esposito P, Piotti G, Bianzina S, Malul Y, Dal Canton A, (2011). The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract 119: c62-c73.
31. Faruque OM, Le-Nguyen D, Lajoix AD, Vives E, Petit P, Bataille D, et al,. (2009). Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring. Am J Physiol Cell Physiol 296: C306-C316.
32. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P, (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592. (Pubitemid 46359643)
33. Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, et al,. (2008). Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 100: 437-442. (Pubitemid 351480514)
34. Fraser ID, Tavalin SJ, Lester LB, Langeberg LK, Westphal AM, Dean RA, et al,. (1998). A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J 17: 2261-2272. (Pubitemid 28171911)
35. Gelman IH, (2002). The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci 7: d1782-d1797.
36. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al,. (2007). Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297: 1332-1343. (Pubitemid 46513234)
37. Gillingham AK, Munro S, (2000). The PACT domain, a conserved centrosomal targeting motif in the coiled-coil proteins AKAP450 and pericentrin. EMBO Rep 1: 524-529.
38. Gold MG, Lygren B, Dokurno P, Hoshi N, McConnachie G, Tasken K, et al,. (2006). Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell 24: 383-395. (Pubitemid 44647900)
39. Gordon T, Grove B, Loftus JC, O'Toole T, McMillan R, Lindstrom J, et al,. (1992). Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest 90: 992-999.
40. Henn V, Edemir B, Stefan E, Wiesner B, Lorenz D, Theilig F, et al,. (2004). Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J Biol Chem 279: 26654-26665. (Pubitemid 38798823)
41. Hofmann B, Nishanian P, Nguyen T, Insixiengmay P, Fahey JL, (1993). Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci USA 90: 6676-6680. (Pubitemid 23207276)
42. Huang LJ, Wang L, Ma Y, Durick K, Perkins G, Deerinck TJ, et al,. (1999). NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum. J Cell Biol 145: 951-959. (Pubitemid 29270054)
43. Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, Tung YC, et al,. (2011). Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes 60: 925-935.
44. Hughes L, Wingate J, Griffith R, Aitken RJ, (2007). Modelling and measuring redox cycling and cytotoxicity of quinones. Drug Metab Lett 1: 245-253.
45. Hughes LM, Griffith R, Carey A, Butler T, Donne SW, Beagley KW, et al,. (2009). The spermostatic and microbicidal actions of quinones and maleimides: toward a dual-purpose contraceptive agent. Mol Pharmacol 76: 113-124.
46. + channel and modulates its function. J Biol Chem 277: 4079-4087. (Pubitemid 34968665)
47. Hundsrucker C, Klussmann E, (2008). Direct AKAP-mediated protein-protein interactions as potential drug targets. Handb Exp Pharmacol 186: 483-503.
48. Hundsrucker C, Krause G, Beyermann M, Prinz A, Zimmermann B, Diekmann O, et al,. (2006a). High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides. Biochem J 396: 297-306. (Pubitemid 43837245)
49. Hundsrucker C, Rosenthal W, Klussmann E, (2006b). Peptides for disruption of PKA anchoring. Biochem Soc Trans 34: 472-473. (Pubitemid 44230738)
50. Josefsen K, Lee YC, Thams P, Efendic S, Nielsen JH, (2010). AKAP 18 alpha and gamma have opposing effects on insulin release in INS-1E cells. FEBS Lett 584: 81-85.
51. Jurado S, Biou V, Malenka RC, (2010). A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression. Nat Neurosci 13: 1053-1055.
52. Kammerer S, Burns-Hamuro LL, Ma Y, Hamon SC, Canaves JM, Shi MM, et al,. (2003). Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci U S A 100: 4066-4071. (Pubitemid 36418158)
53. Kapiloff MS, Schillace RV, Westphal AM, Scott JD, (1999). mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 112: 2725-2736. (Pubitemid 29429795)
54. Kapiloff MS, Jackson N, Airhart N, (2001). mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci 114: 3167-3176. (Pubitemid 32910471)
55. Kinderman FS, Kim C, von Daake S, Ma Y, Pham BQ, Spraggon G, et al,. (2006). A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Mol Cell 24: 397-408. (Pubitemid 44647908)
56. King LS, Kozono D, Agre P, (2004). From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol 5: 687-698. (Pubitemid 39208179)
57. Klussmann E, Rosenthal W, (2008). Protein-protein interactions as new drug targets. Preface. Handb Exp Pharmacol 186: v-vi.
58. Klussmann E, Maric K, Wiesner B, Beyermann M, Rosenthal W, (1999). Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem 274: 4934-4938.
59. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al,. (2007). Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297: 1319-1331. (Pubitemid 46513233)
60. Kovanich D, van der Heyden MA, Aye TT, van Veen TA, Heck AJ, Scholten A, (2010). Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. Chembiochem 11: 963-971.
61. Kritzer MD, Li J, Dodge-Kafka K, Kapiloff MS, (2011). AKAPs: the architectural underpinnings of local cAMP signaling. J Mol Cell Cardiol. Epub ahead of print.
62. Kurokawa J, Motoike HK, Rao J, Kass RS, (2004). Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation. Proc Natl Acad Sci U S A 101: 16374-16378. (Pubitemid 39552852)
63. Kwon TH, Nielsen J, Moller HB, Fenton RA, Nielsen S, Frokiaer J, (2009). Aquaporins in the kidney. Handb Exp Pharmacol 190: 95-132.
64. Lemay J, Maidou-Peindara P, Cancio R, Ennifar E, Coadou G, Maga G, et al,. (2008). AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription. J Mol Biol 383: 783-796.
65. Lester LB, Langeberg LK, Scott JD, (1997). Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA 94: 14942-14947. (Pubitemid 28041479)
66. Lester LB, Faux MC, Nauert JB, Scott JD, (2001). Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. Endocrinology 142: 1218-1227. (Pubitemid 32202832)
67. Lezoualc'h F, Metrich M, Hmitou I, Duquesnes N, Morel E, (2008). Small GTP-binding proteins and their regulators in cardiac hypertrophy. J Mol Cell Cardiol 44: 623-632.
68. Li J, Negro A, Lopez J, Bauman AL, Henson E, Dodge-Kafka K, et al,. (2010). The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J Mol Cell Cardiol 48: 387-394.
69. Lin X, Gelman IH, (1997). Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res 57: 2304-2312. (Pubitemid 27247053)
70. Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH, (1996). A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 271: 28430-28438. (Pubitemid 26374662)
71. Liu W, Guan M, Su B, Li J, Ma W, Liu C, et al,. (2010). Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer. Clin Chim Acta 411: 940-946.
72. Lu Y, Allen M, Halt AR, Weisenhaus M, Dallapiazza RF, Hall DD, et al,. (2007). Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP. EMBO J 26: 4879-4890. (Pubitemid 350191298)
73. Luconi M, Carloni V, Marra F, Ferruzzi P, Forti G, Baldi E, (2004). Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A. J Cell Sci 117: 1235-1246. (Pubitemid 38456104)
74. Luconi M, Cantini G, Baldi E, Forti G, (2011). Role of a-kinase anchoring proteins (AKAPs) in reproduction. Front Biosci 16: 1315-1330.
75. Lygren B, Tasken K, (2008). The potential use of AKAP18delta as a drug target in heart failure patients. Expert Opin Biol Ther 8: 1099-1108.
76. + re-uptake into heart sarcoplasmic reticulum. EMBO Rep 8: 1061-1067. (Pubitemid 350042342)
77. Ma Y, Taylor S, (2002). A 15-residue bifunctional element in D-AKAP1 is required for both endoplasmic reticulum and mitochondrial targeting. J Biol Chem 277: 27328-27336. (Pubitemid 34951752)
78. Ma Y, Taylor SS, (2008). A molecular switch for targeting between endoplasmic reticulum (ER) and mitochondria: conversion of a mitochondria-targeting element into an ER-targeting signal in DAKAP1. J Biol Chem 283: 11743-11751.
79. Malbon CC, Tao J, Shumay E, Wang HY, (2004). AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans 32: 861-864. (Pubitemid 39524398)
80. Martin SJ, Morris RG, (2002). New life in an old idea: the synaptic plasticity and memory hypothesis revisited. Hippocampus 12: 609-636. (Pubitemid 35363956)
81. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al,. (2000). PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376.
82. Marx SO, Reiken S, Hisamatsu Y, Gaburjakova M, Gaburjakova J, Yang YM, et al,. (2001). Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J Cell Biol 153: 699-708. (Pubitemid 34286103)
83. Mauban JRH, O'Donnell M, Warrier S, Manni S, Bond M, (2009). AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology 24: 78-87.
84. Mayers CM, Wadell J, McLean K, Venere M, Malik M, Shibata T, et al,. (2010). The rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J Biol Chem 285: 12344-12354.
85. McConnell BK, Popovic Z, Mal N, Lee K, Bautista J, Forudi F, et al,. (2009). Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem 284: 1583-1592.
86. Medrihan L, Rohlmann A, Fairless R, Andrae J, Doring M, Missler M, et al,. (2009). Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses. J Physiol 587: 5095-5106.
87. Miki H, Takenawa T, (2003). Regulation of actin dynamics by WASP family proteins. J Biochem 134: 309-313. (Pubitemid 37288327)
88. Miki K, Willis WD, Brown PR, Goulding EH, Fulcher KD, Eddy EM, (2002). Targeted disruption of the Akap4 gene causes defects in sperm flagellum and motility. Dev Biol 248: 331-342. (Pubitemid 35002093)
89. Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T, (2007). Tolvaptan, an orally active vasopressin V(2)-receptor antagonist-pharmacology and clinical trials. Cardiovasc Drug Rev 25: 1-13. (Pubitemid 46625287)
90. Moretti E, Scapigliati G, Pascarelli NA, Baccetti B, Collodel G, (2007). Localization of AKAP4 and tubulin proteins in sperm with reduced motility. Asian J Androl 9: 641-649. (Pubitemid 47354666)
91. Mosenden R, Tasken K, (2011). Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell Signal 23: 1009-1016.
92. Mosenden R, Singh P, Cornez I, Heglind M, Ruppelt A, Moutschen M, et al,. (2011). Mice with disrupted type I protein kinase a anchoring in T cells resist retrovirus-induced immunodeficiency. J Immunol 186: 5119-5130.
93. Movsesian MA, Bristow MR, (2005). Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol 68: 25-48. (Pubitemid 43588862)
94. Nauert JB, Rigas JD, Lester LB, (2003). Identification of an IQGAP1/AKAP79 complex in beta-cells. J Cell Biochem 90: 97-108.
95. + sparklets and angiotensin II-induced hypertension. Circ Res 102: e1-e11. (Pubitemid 351651131)
96. Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E, (2009). Regulation of aquaporin-2 trafficking. Handb Exp Pharmacol 190: 133-157.
97. Negro A, Dodge-Kafka K, Kapiloff MS, (2008). Signalosomes as therapeutic targets. Prog Pediatr Cardiol 25: 51-56.
98. Neumann SA, Tingley WG, Conklin BR, Shrader CJ, Peet E, Muldoon MF, et al,. (2009). AKAP10 (I646V) functional polymorphism predicts heart rate and heart rate variability in apparently healthy, middle-aged European-Americans. Psychophysiology 46: 466-472.
99. Newhall KJ, Criniti AR, Cheah CS, Smith KC, Kafer KE, Burkart AD, et al,. (2006). Dynamic anchoring of PKA is essential during oocyte maturation. Curr Biol 16: 321-327. (Pubitemid 43190233)
100. Newlon MG, Roy M, Morikis D, Hausken ZE, Coghlan V, Scott JD, et al,. (1999). The molecular basis for protein kinase A anchoring revealed by solution NMR. Nat Struct Biol 6: 222-227. (Pubitemid 29107224)
101. Newlon MG, Roy M, Morikis D, Carr DW, Westphal R, Scott JD, et al,. (2001). A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J 20: 1651-1662. (Pubitemid 32299402)
102. Nichols CB, Rossow CF, Navedo MF, Westenbroek RE, Catterall WA, Santana LF, et al,. (2010). Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 107: 747-756.
103. Numata S, Iga J, Nakataki M, Tayoshi S, Tanahashi T, Itakura M, et al,. (2009). Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population. J Psychiatry Neurosci 34: 195-198.
104. Numata S, Nakataki M, Iga J, Tanahashi T, Nakadoi Y, Ohi K, et al,. (2010). Association study between the pericentrin (PCNT) gene and schizophrenia. Neuromolecular Med 12: 243-247.
105. O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, et al,. (2010). Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J 159: 841-849 e841.
106. Pare GC, Easlick JL, Mislow JM, McNally EM, Kapiloff MS, (2005a). Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res 303: 388-399. (Pubitemid 40126271)
107. Pare GC, Bauman AL, McHenry M, Michel JJ, Dodge-Kafka KL, Kapiloff MS, (2005b). The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci 118: 5637-5646. (Pubitemid 43079302)
108. Patel HH, Hamuro LL, Chun BJ, Kawaraguchi Y, Quick A, Rebolledo B, et al,. (2010). Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function. J Biol Chem 285: 27632-27640.
109. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al,. (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
110. Pidoux G, Tasken K, (2010). Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J Mol Endocrinol 44: 271-284.
111. Rauch A, (2011). The shortest of the short: pericentrin mutations and beyond. Best Pract Res Clin Endocrinol Metab 25: 125-130.
112. Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, Ekici AB, et al,. (2008). Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science 319: 816-819. (Pubitemid 351225872)
113. Rawe VY, Payne C, Navara C, Schatten G, (2004a). WAVE1 intranuclear trafficking is essential for genomic and cytoskeletal dynamics during fertilization: cell-cycle-dependent shuttling between M-phase and interphase nuclei. Dev Biol 276: 253-267. (Pubitemid 39592392)
114. Rawe VY, Ramalho-Santos J, Payne C, Chemes HE, Schatten G, (2004b). WAVE1, an A-kinase anchoring protein, during mammalian spermatogenesis. Hum Reprod 19: 2594-2604. (Pubitemid 39481288)
115. Rosenmund C, Carr DW, Bergeson SE, Nilaver G, Scott JD, Westbrook GL, (1994). Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 368: 853-856. (Pubitemid 24137749)
116. Ruppelt A, Mosenden R, Gronholm M, Aandahl EM, Tobin D, Carlson CR, et al,. (2007). Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J Immunol 179: 5159-5168.
117. Scanlan MJ, Simpson AJ, Old LJ, (2004). The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4: 1.
118. Schillace RV, Miller CL, Pisenti N, Grotzke JE, Swarbrick GM, Lewinsohn DM, et al,. (2009). A-kinase anchoring in dendritic cells is required for antigen presentation. PLoS ONE 4: e4807.
119. Schillace RV, Miller CL, Carr DW, (2011). AKAPs in lipid rafts are required for optimal antigen presentation by dendritic cells. Immunol Cell Biol 89: 650-658.
120. Schrier RW, Cadnapaphornchai MA, (2003). Renal aquaporin water channels: from molecules to human disease. Prog Biophys Mol Biol 81: 117-131. (Pubitemid 36141257)
121. Schulze DH, Muqhal M, Lederer WJ, Ruknudin AM, (2003). Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem 278: 28849-28855. (Pubitemid 36935795)
122. Scott JD, Santana LF, (2010). A-kinase anchoring proteins: getting to the heart of the matter. Circulation 121: 1264-1271.
123. Sit ST, Manser E, (2011). Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci 124: 679-683.
124. Skalhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T, (1994). Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 263: 84-87. (Pubitemid 24076260)
125. Skroblin P, Grossmann S, Schafer G, Rosenthal W, Klussmann E, (2010). Mechanisms of protein kinase A anchoring. Int Rev Cell Mol Biol 283: 235-330.
126. Smith M, Woodroffe A, Smith R, Holguin S, Martinez J, Filipek PA, et al,. (2002). Molecular genetic delineation of a deletion of chromosome 13q12->q13 in a patient with autism and auditory processing deficits. Cytogenet Genome Res 98: 233-239. (Pubitemid 37499851)
127. Smith FD, Langeberg LK, Cellurale C, Pawson T, Morrison DK, Davis RJ, et al,. (2010). AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat Cell Biol 12: 1242-1249.
128. Soderling TR, Derkach VA, (2000). Postsynaptic protein phosphorylation and LTP. Trends Neurosci 23: 75-80. (Pubitemid 30084764)
129. Soderling SH, Langeberg LK, Soderling JA, Davee SM, Simerly R, Raber J, et al,. (2003). Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice. Proc Natl Acad Sci U S A 100: 1723-1728. (Pubitemid 36254515)
130. Su B, Bu Y, Engelberg D, Gelman IH, (2010). SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem 285: 4578-4586.
131. Suri A, (2005). Contraceptive vaccines targeting sperm. Expert Opin Biol Ther 5: 381-392. (Pubitemid 40516748)
132. Szaszak M, Christian F, Rosenthal W, Klussmann E, (2008). Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells. Cell Signal 20: 590-601. (Pubitemid 351241129)
133. Tao J, Shumay E, McLaughlin S, Wang HY, Malbon CC, (2006). Regulation of AKAP-membrane interactions by calcium. J Biol Chem 281: 23932-23944. (Pubitemid 44274168)
134. Tasken K, Aandahl EM, (2004). Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84: 137-167. (Pubitemid 38049878)
135. Tingley WG, Pawlikowska L, Zaroff JG, Kim T, Nguyen T, Young SG, et al,. (2007). Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation. Proc Natl Acad Sci USA 104: 8461-8466. (Pubitemid 47175510)
136. Torheim EA, Jarnaess E, Lygren B, Tasken K, (2009). Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochem J 424: 69-78.
137. Trotter KW, Fraser ID, Scott GK, Stutts MJ, Scott JD, Milgram SL, (1999). Alternative splicing regulates the subcellular localization of A-kinase anchoring protein 18 isoforms. J Cell Biol 147: 1481-1492. (Pubitemid 30027403)
138. Tunquist BJ, Hoshi N, Guire ES, Zhang F, Mullendorff K, Langeberg LK, et al,. (2008). Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc Natl Acad Sci USA 105: 12557-12562.
139. Turner RM, Foster JA, Gerton GL, Moss SB, Patrizio P, (2001). Molecular evaluation of two major human sperm fibrous sheath proteins, pro-hAKAP82 and hAKAP82, in stump tail sperm. Fertil Steril 76: 267-274. (Pubitemid 32703813)
140. Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Skalhegg BS, et al,. (2001). Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193: 497-507. (Pubitemid 32524480)
141. Vijayaraghavan S, Goueli SA, Davey MP, Carr DW, (1997). Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility. J Biol Chem 272: 4747-4752. (Pubitemid 27090017)
142. Vijayaraghavan S, Liberty GA, Mohan J, Winfrey VP, Olson GE, Carr DW, (1999). Isolation and molecular characterization of AKAP110, a novel, sperm-specific protein kinase A-anchoring protein. Mol Endocrinol 13: 705-717. (Pubitemid 30645324)
143. Wan M, Sun T, Vyas R, Zheng J, Granada E, Dubeau L, (1999). Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25. Oncogene 18: 1545-1551. (Pubitemid 29108054)
144. Webb RJ, Tinworth L, Thomas GM, Zaccolo M, Carroll J, (2008). Developmentally acquired PKA localisation in mouse oocytes and embryos. Dev Biol 317: 36-45.
145. Weisenhaus M, Allen ML, Yang L, Lu Y, Nichols CB, Su T, et al,. (2010). Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice. PLoS ONE 5: e10325.
146. Welch EJ, Jones BW, Scott JD, (2010). Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 10: 86-97.
147. Wells JA, McClendon CL, (2007). Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009. (Pubitemid 350273630)
148. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, et al,. (2001). Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98: 1176-1181. (Pubitemid 32121206)
149. Willems M, Genevieve D, Borck G, Baumann C, Baujat G, Bieth E, et al,. (2010). Molecular analysis of pericentrin gene (PCNT) in a series of 24
150. Wirtenberger M, Tchatchou S, Hemminki K, Klaes R, Schmutzler RK, Bermejo JL, et al,. (2005). Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. Carcinogenesis 27: 593-598. (Pubitemid 43372887)
151. Wirtenberger M, Schmutzhard J, Hemminki K, Meindl A, Sutter C, Schmutzler RK, et al,. (2007). The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer. Carcinogenesis 28: 423-426. (Pubitemid 46321859)
152. Wong W, Scott JD, (2004). AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5: 959-970. (Pubitemid 39611533)
153. Wu W, Zhang J, Yang H, Shao Y, Yu B, (2011). Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis. Clin Exp Dermatol 36: 381-385.
154. Xia W, Unger P, Miller L, Nelson J, Gelman IH, (2001). The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 61: 5644-5651. (Pubitemid 32694952)
155. Yan X, Walkiewicz M, Carlson J, Leiphon L, Grove B, (2009). Gravin dynamics regulates the subcellular distribution of PKA. Exp Cell Res 315: 1247-1259.